Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.35M Sell
439,621
-248,582
-36% -$891K ﹤0.01% 2055
2026
Q1
$2.3M Buy
688,203
+541,403
+369% +$1.8M ﹤0.01% 1708
2025
Q4
$461K Buy
146,800
+33,487
+30% +$133K ﹤0.01% 2269
2025
Q3
$436K Sell
113,313
-319,166
-74% -$1.6M ﹤0.01% 2283
2025
Q2
$1.98M Buy
+432,479
New +$1.5M ﹤0.01% 1571
2022
Q2
Sell
-10,337
Closed -$499K 3371
2022
Q1
$499K Buy
+10,337
New +$559K ﹤0.01% 2772
2020
Q2
Sell
-2,855
Closed -$137K 1499
2020
Q1
$137K Buy
+2,855
New +$179K ﹤0.01% 1264
2019
Q3
Sell
-8,451
Closed -$498K 1646
2019
Q2
$498K Buy
8,451
+8,448
+281,600% +$462K ﹤0.01% 1084
2019
Q1
$0 Buy
+3
New +$186 ﹤0.01% 1684
2017
Q1
Sell
-25,276
Closed -$2.04M 305
2016
Q4
$2.04M Buy
+25,276
New +$2.48M 0.01% 630

Other funds holding AGEN

Marshall Wace's AGEN Position: Q2 2026 in Review

Marshall Wace reduced its Agenus (AGEN) stake by 36% in Q2 2026, selling an estimated $891K and leaving 439,621 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2055.

Marshall Wace first reported a position in AGEN in Q4 2016 and has held it in 10 quarters since. The position peaked at $2.3M in Q1 2026. 103 funds tracked by Wall St. Rank hold AGEN as of Q2 2026.

  • Marshall Wace held 439,621 shares of Agenus worth $1.35M as of Q2 2026.
  • Marshall Wace sold 248,582 Agenus shares in Q2 2026, an estimated $891K.
  • Agenus made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2055 holding.
  • Marshall Wace first reported a position in Agenus in Q4 2016 and has held it in 10 quarters since.
  • Marshall Wace's Agenus position peaked at $2.3M in Q1 2026.
  • 103 funds tracked by Wall St. Rank held Agenus as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.